CBD and THC: What’s Different, What’s Proven, and What to Consider
CBD and THC come from the same cannabis plant, but they are not interchangeable. Their effects, medical evidence, legal status, and potential risks differ significantly. Understanding those differences is important before using cannabis or a cannabis-derived product.
CBD and THC explained
Cannabidiol (CBD) is a cannabis compound that does not typically produce the intoxicating “high” associated with marijuana. Delta-9-tetrahydrocannabinol (THC) is the primary compound responsible for cannabis’s intoxicating effects. THC can affect memory, attention, coordination, reaction time, mood, and decision-making.
The two compounds may appear together in cannabis products, but one does not reliably cancel out the effects of the other. A product’s THC concentration, dose, delivery method, and a person’s experience with cannabis all influence its effects.
What the evidence shows about CBD
CBD has received substantial scientific attention, but research does not support treating it as a general-purpose wellness medicine. In the United States, the Food and Drug Administration has approved one CBD medication: Epidiolex, a purified oral CBD product used under medical supervision for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
That approval does not extend to the many oils, gummies, capsules, creams, and other CBD products sold online or in stores. The FDA says most of those products have not been evaluated for safety, effectiveness, appropriate dosage, drug interactions, or manufacturing quality. Some products have contained different amounts of CBD than their labels indicated, as well as THC or contaminants.
Research into CBD for pain, inflammation, anxiety, osteoporosis, and other conditions is ongoing. Findings from laboratory and animal studies cannot by themselves establish that CBD is an effective treatment for people. Anyone considering CBD for a medical condition should discuss it with a health professional rather than using it as a substitute for proven care.
How THC differs
THC is intoxicating and can impair driving, work performance, balance, and judgment. It can also cause anxiety, panic, dizziness, or an increased heart rate, particularly at higher doses or in people who are inexperienced with cannabis. Edibles can be especially difficult to dose because their effects may take longer to begin and can last longer than expected.
THC also carries a risk of problematic use. The Centers for Disease Control and Prevention reports that approximately three in 10 people who use cannabis may develop cannabis use disorder, although individual risk varies. Frequent use, starting during adolescence, and using high-THC products are associated with greater risk. Some people who stop regular use experience irritability, sleep problems, reduced appetite, cravings, or other withdrawal symptoms.
Higher-potency cannabis is more common than it was decades ago. A 2021 systematic review and meta-analysis found substantial increases in THC concentrations in cannabis products examined between 1970 and 2017. That trend makes product labels and dose information increasingly important, although potency measurements vary by product, market, and testing method.
Products and regulation
Cannabis products may include dried flower, vapes, concentrates, edibles, tinctures, capsules, and topicals. Their availability depends on state law. Federal and state rules are not always aligned, and products sold through state-licensed cannabis markets are not the same as FDA-approved medicines.
Under federal law, hemp is cannabis containing no more than 0.3% THC by dry weight, but a hemp-derived product can still contain enough THC to cause impairment or produce a positive drug test. The FDA also says that CBD cannot currently be marketed lawfully as a conventional food or dietary supplement under the agency’s existing framework.
CBD may interact with prescription medicines and has been associated with side effects such as drowsiness, diarrhea, changes in appetite, and possible liver injury. The FDA advises particular caution for people who are pregnant or breastfeeding, people taking other medications, and anyone considering CBD for a child.
Drug testing and safer decision-making
Most workplace tests for marijuana look for THC or its metabolites, not CBD itself. However, products labeled “CBD” or “hemp” may contain THC, even when the label does not make that clear. Detection depends on the type of specimen, the test used, the amount and frequency of use, and individual factors. There is no universal 30-day rule that guarantees a negative result.
The Substance Abuse and Mental Health Services Administration explains that federal testing programs may analyze urine or oral fluid for marijuana-related compounds, among other substances. Anyone subject to workplace, athletic, legal, or medical testing should review the applicable policy rather than relying on a general estimate.
The central distinction is straightforward: CBD is generally nonintoxicating but is not risk-free or broadly proven as a treatment, while THC is intoxicating and can lead to impairment and cannabis use disorder. Before using either compound, check the laws where you live, examine the product’s ingredients and testing information, and consult a qualified medical professional about potential benefits, risks, and drug interactions.
